Brown-Forman Corporation
BF-B
$26.04
+1.56%
Brown-Forman Corporation is a leading producer and marketer of premium alcoholic beverages, operating in the Beverages - Wineries & Distilleries industry with a portfolio anchored by the iconic Jack Daniel's Tennessee Whiskey brand. The company is a well-established market leader in the American whiskey category, with a distinct competitive identity built on a deep heritage, strong brand equity, and a diversified portfolio that includes tequila, vodka, ready-to-drink cocktails, and wines. The current investor narrative revolves around navigating a challenging macroeconomic environment for consumer staples, with debates centered on the company's ability to maintain pricing power and volume growth amidst potential consumer downtrading, as evidenced by recent analyst rating actions and a stock price that has significantly underperformed the broader market over the past year.…
BF-B
Brown-Forman Corporation
$26.04
Investment Opinion: Should I buy BF-B Today?
Rating & Thesis: Hold. Brown-Forman is a high-quality company caught in a sector downdraft, offering a compelling long-term value proposition but lacking a near-term catalyst for a re-rating, as reflected in the neutral-to-cautious analyst consensus. The investment thesis hinges on patience, betting that the company's durable brand equity and financial strength will eventually be rewarded as macro concerns abate.
Supporting Evidence: The Hold rating is supported by a forward P/E of 15.03x, which prices in modest growth, a robust net margin of 25.12% that is expanding sequentially, and substantial shareholder returns via a 2.55% dividend and buybacks. The stock trades at a significant discount to its own historical valuation (trailing P/E of 18.95x vs. past levels above 30x), and its low beta of 0.42 provides defensive characteristics. However, these positives are counterbalanced by anemic 2.71% revenue growth and severe technical damage (-22.7% over 1 year).
Risks & Conditions: The two biggest risks are a further deterioration in consumer spending on premium spirits, threatening volumes and margins, and a prolonged period of valuation compression for the sector. This Hold would upgrade to a Buy if revenue growth re-accelerates above 5% on a sustained basis or if the forward P/E compresses further toward 12x. It would downgrade to a Sell if quarterly revenue growth turns negative or if net margins contract below 20%. On balance, the stock appears fairly valued relative to its near-term growth prospects but undervalued relative to its long-term brand strength and profitability.
Sign up to view all
BF-B 12-Month Price Forecast
The AI assessment is neutral with medium confidence. Brown-Forman presents a classic 'value vs. value trap' scenario. The quantitative case for value is strong: profitability is high, the balance sheet is clean, and the valuation is at a multi-year low. However, the qualitative growth outlook is murky, with the stock's performance heavily dependent on a macroeconomic rebound for consumer discretionaries. The stance would upgrade to bullish on evidence of revenue re-acceleration above 4% or a decisive technical breakout above the $30.31 resistance level. It would turn bearish on a breakdown below the $22.61 support coupled with a margin contraction.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Brown-Forman Corporation's 12-month outlook, with a consensus price target around $33.85 and implied upside of +30.0% versus the current price.
Average Target
$33.85
16 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
16
covering this stock
Price Range
$21 - $34
Analyst target range
The stock is covered by 16 analysts, indicating substantial institutional interest. The consensus sentiment appears neutral to cautious, as reflected in recent rating actions where firms like Citigroup and JP Morgan moved to Neutral from more bearish stances, while Bernstein downgraded from Outperform to Market Perform; the distribution of ratings likely leans towards Hold, given these adjustments. While specific average target price and upside/downside calculations are not provided in the data, the range of analyst EPS estimates offers insight: the estimated EPS range is $1.71 (low) to $1.81 (high), with an average of $1.78, and the revenue estimate range is $4.24 billion to $4.43 billion, with an average of $4.36 billion. The high-end EPS estimate of $1.81 assumes successful execution on pricing, mix, and volume growth, while the low-end estimate of $1.71 likely factors in greater macroeconomic headwinds or competitive pressures; the relatively tight spread between the high and low EPS estimates (a difference of only $0.10) suggests analysts have a reasonable degree of consensus on the near-term earnings trajectory, though the recent downgrades indicate rising concerns.
Bulls vs Bears: BF-B Investment Factors
The evidence currently tilts bearish, as reflected in the stock's severe price decline, anemic revenue growth, and recent analyst downgrades. However, the bearish case is largely priced in, creating a compelling tension with the company's underlying strengths: robust profitability, a fortress balance sheet, and a valuation now at a historical discount. The single most important factor in the investment debate is whether Brown-Forman's pricing power and brand equity can sustain margins and reignite modest volume growth in the face of potential consumer downtrading. The resolution of this fundamental question will determine if the current price represents a value trap or a value opportunity.
Bullish
- Strong Profitability & Margin Expansion: The company's net margin expanded from 21.52% in Q2 2026 to 25.12% in Q3 2026, demonstrating effective cost management. A robust gross margin of 60.87% and a return on equity of 21.76% underscore a high-quality, profitable business model.
- Healthy Balance Sheet & Cash Generation: Brown-Forman has a strong current ratio of 3.88 and a manageable debt-to-equity ratio of 0.68. It generated $730 million in trailing twelve-month free cash flow, funding a sustainable 2.55% dividend yield (48.33% payout ratio) and $301 million in share buybacks last quarter.
- Compressed Valuation Presents Opportunity: The stock trades at a trailing P/E of 18.95x, which is below its own historical range that has frequently been above 20x and even 30x. The forward P/E of 15.03x implies a discount for expected earnings growth, potentially creating a value entry point.
- Deeply Oversold Technical Condition: The stock is down 22.70% over the past year, severely underperforming the S&P 500 by -51.74%. Trading at 29% of its 52-week range ($22.61-$36.18), it is deeply oversold, which can precede a technical rebound if fundamentals stabilize.
Bearish
- Severe Price & Relative Underperformance: The stock has declined 22.70% over the past year while the S&P 500 gained 29.04%, resulting in a massive -51.74% relative strength deficit. This persistent downtrend, with the stock near its 52-week low, signals deep-seated investor pessimism.
- Anemic Revenue Growth Trajectory: Recent quarterly revenue grew only 2.71% year-over-year to $1.063 billion. The portfolio is heavily reliant on the mature Whiskey segment ($797M), with smaller segments like Tequila ($60M) not yet large enough to drive meaningful top-line acceleration.
- Analyst Downgrades & Cautious Sentiment: Recent analyst actions reflect rising concerns, with Citigroup and JP Morgan moving to Neutral and Bernstein downgrading from Outperform to Market Perform. The consensus leans towards Hold, indicating a lack of conviction for a near-term rebound.
- Macro Sensitivity & Consumer Downtrading Risk: As a premium spirits producer, the company faces risks from a challenging macroeconomic environment where consumers may trade down to lower-priced brands. The tight $0.10 spread between high ($1.81) and low ($1.71) EPS estimates reflects this uncertainty.
BF-B Technical Analysis
The stock is in a pronounced and sustained downtrend, having declined 22.70% over the past year, which starkly contrasts with the S&P 500's 29.04% gain, resulting in a severe relative strength deficit of -51.74%. With a current price of $25.55, the stock is trading near the lower end of its 52-week range of $22.61 to $36.18, positioning it at approximately 29% of this range, which suggests it is deeply oversold and may represent a value opportunity, though it also risks being a 'falling knife' if the fundamental outlook continues to deteriorate. Short-term momentum shows some signs of stabilization but remains weak, with the stock down 3.62% over the past month and 5.79% over the past three months, though these losses are less severe than the annual decline, indicating the rate of descent may be slowing; however, the stock's 1-month relative strength of -13.60 against the market confirms it is still lagging significantly. Key technical support is clearly defined at the 52-week low of $22.61, while resistance sits at the 52-week high of $36.18; a decisive breakdown below $22.61 would signal a continuation of the bearish trend, whereas a sustained move above the recent high near $30.31 from April could indicate a potential reversal. The stock's beta of 0.421 indicates it is significantly less volatile than the broader market, which is typical for a consumer defensive name, but this low beta has not shielded it from substantial absolute price declines during this period of sector-specific weakness.
Beta
0.35
0.35x market volatility
Max Drawdown
-51.9%
Largest decline past year
52-Week Range
$23-$35
Price range past year
Annual Return
-22.5%
Cumulative gain past year
| Period | BF-B Return | S&P 500 |
|---|---|---|
| 1m | -9.4% | +5.5% |
| 3m | -12.4% | +7.7% |
| 6m | -6.9% | +12.7% |
| 1y | -22.5% | +27.4% |
| ytd | +0.5% | +8.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
BF-B Fundamental Analysis
Revenue growth has been modest but positive, with the most recent quarterly revenue of $1.063 billion representing a 2.71% year-over-year increase; however, segment data indicates the growth is heavily reliant on the Whiskey category, which contributed $797 million, while other segments like Ready-to-Drink ($146 million) and Tequila ($60 million) represent smaller, though potentially faster-growing, components of the portfolio. The company remains solidly profitable, reporting net income of $267 million for the last quarter, supported by a robust gross margin of 60.87%; profitability metrics have shown improvement sequentially, with the net margin expanding from 21.52% in the prior quarter (Q2 2026) to 25.12% in Q3 2026, and the operating margin also rising from 29.49% to 32.27% over the same period, indicating effective cost management. The balance sheet is healthy with a strong current ratio of 3.88 and a manageable debt-to-equity ratio of 0.68; the company is generating substantial cash flow, with free cash flow over the trailing twelve months of $730 million, providing ample liquidity to fund its dividend (payout ratio of 48.33%) and share repurchases, as evidenced by $301 million in buybacks in the last quarter, while maintaining a return on equity of 21.76%.
Quarterly Revenue
$1.1B
2026-01
Revenue YoY Growth
+0.02%
YoY Comparison
Gross Margin
+0.60%
Latest Quarter
Free Cash Flow
$730000000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is BF-B Overvalued?
Given the company's consistent profitability, the primary valuation metric selected is the Price-to-Earnings (PE) ratio. The stock trades at a trailing PE of 18.95x and a forward PE of 15.03x based on estimated EPS; the discount of the forward multiple implies the market expects earnings growth, aligning with analyst EPS estimates averaging $1.78 for the coming period. Compared to sector averages, Brown-Forman's valuation presents a mixed picture: its trailing PE of 18.95x is below the typical premium often commanded by high-quality branded consumer staples, while its Price-to-Sales ratio of 4.14x and EV/EBITDA of 14.54x need to be assessed in the context of its superior margins and return profile relative to many peers. Historically, the current trailing PE of 18.95x sits well below the stock's own historical range observed in the provided data, which has seen quarterly PE ratios frequently above 20x and even above 30x in recent years; this compression towards the lower end of its historical band suggests the market is pricing in a more pessimistic outlook on growth or margins, potentially creating a value opportunity if the company's fundamentals stabilize.
PE
18.9x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 12x~80x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
14.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: The primary financial risk is revenue concentration and growth stagnation. The Whiskey segment, dominated by Jack Daniel's, contributed 75% of last quarter's revenue ($797M of $1.063B), creating over-reliance on a single mega-brand in a mature category. While margins are expanding (net margin from 21.52% to 25.12% sequentially), this improvement is occurring on low-single-digit revenue growth, raising questions about sustainability if volumes weaken. The company's healthy balance sheet (D/E 0.68) and strong cash flow mitigate traditional financial risks, but the core operational challenge is reigniting top-line momentum beyond its flagship.
Market & Competitive Risks: The stock faces significant valuation compression risk, as its current trailing P/E of 18.95x, while below its own history, may still be high for a company with ~2.7% revenue growth if investor sentiment continues to sour on consumer staples. Competitive intensity is rising across the spirits landscape, with new entrants and aggressive marketing from rivals threatening market share. The stock's low beta of 0.421 has not shielded it from a 22.7% annual decline, demonstrating potent sector-specific headwinds that could persist if economic conditions pressure discretionary spending on premium alcohol.
Worst-Case Scenario: The worst-case scenario involves a combination of sustained consumer downtrading, leading to volume declines in the core Jack Daniel's franchise, coupled with an inability to maintain recent price increases. This would pressure both revenue growth and the high gross margin of 60.87%, triggering earnings misses relative to the low-end EPS estimate of $1.71. Analyst sentiment would turn overtly negative, driving a re-rating to trough valuation multiples. In this adverse scenario, the stock could realistically retest and break below its 52-week low of $22.61, implying a further downside of approximately -11.5% from the current price of $25.55.
FAQ
The key risks are, in order of severity: 1) Growth Stagnation Risk: Heavy reliance on the mature Jack Daniel's brand with only 2.71% revenue growth, creating vulnerability if volumes decline. 2) Consumer Downtrading Risk: In a weak economy, consumers may trade down from premium brands, pressuring pricing power and the 60.87% gross margin. 3) Valuation Compression Risk: The stock's multiples (P/E 18.95x, EV/EBITDA 14.54x) could contract further if the sector remains out of favor, despite already being below historical averages. 4) Sentiment Risk: The stock has severely underperformed the market (-51.74% relative strength), and further negative analyst actions could prolong the downtrend.
The 12-month forecast presents three scenarios with associated probabilities. The Base Case (60% probability) sees the stock trading between $28 and $32, as steady execution meets modest growth expectations (EPS ~$1.78). The Bull Case (25% probability) projects a range of $33 to $36, driven by earnings outperformance and a sentiment rebound. The Bear Case (15% probability) warns of a drop to $22-$25 if consumer spending weakens significantly. The base case is most likely, anchored by the company's solid fundamentals but capped by low growth visibility. The average analyst EPS estimate of $1.78 serves as the central forecast assumption.
BF-B appears fairly valued to slightly undervalued relative to its current growth profile but significantly undervalued relative to its own history and quality. Its trailing P/E of 18.95x and forward P/E of 15.03x are below the elevated multiples it has historically commanded (often above 20x-30x), suggesting the market is pricing in a more pessimistic outlook. Compared to just its 2.7% revenue growth, the valuation is not cheap, but when factoring in its 60.87% gross margin and 21.76% return on equity, it represents a fair price for a premium asset. The valuation implies the market expects prolonged low growth and has discounted the stock accordingly.
BF-B is a good buy for a specific type of investor: those seeking a high-quality, defensive name with a reliable dividend, trading at a discount to its historical valuation. The forward P/E of 15.03x is reasonable for its profitability profile (21.76% ROE), and the 2.55% dividend is well-covered. However, it is not a good buy for investors seeking rapid growth, as revenue is only expanding at 2.71% annually. The key risk is further deterioration in consumer spending, which could push the stock toward its 52-week low of $22.61. It is a good buy for patient, value-oriented investors comfortable with potential near-term stagnation.
BF-B is unequivocally more suitable for a long-term investment horizon (3-5 years minimum). As a slow-growth, defensive consumer staples company with a low beta of 0.42, it lacks the catalysts and volatility typically sought by short-term traders. Its value proposition is the compounding of its reliable dividend and the potential for a valuation re-rating as its brand strength and cash generation are eventually recognized. The stock's severe underperformance over the past year may take multiple quarters or years to reverse. Therefore, it is best suited for long-term portfolios seeking income, capital preservation, and exposure to a timeless brand at a reasonable price.